XRAY

Dentsply Sirona Issues FY25 Outlook

(RTTNews) - Dentsply Sirona (XRAY) announced 2025 outlook, which includes anticipated net sales in the range of $3.50 billion to $3.60 billion, down 4.0% to 2.0% on an organic basis. Adjusted EPS is expected to be in the range of $1.80 to $2.00.

Simon Campion, CEO, said: "In 2025, we anticipate the external environment to remain broadly unchanged, with our transformational initiatives driving EBITDA margin expansion and adjusted EPS growth."

Fourth quarter net loss was $430 million, or $2.16 per share, compared to net income of $67 million, or $0.32 per share, a year ago. Adjusted earnings per share were $0.26 compared to $0.44. Analysts on average expected the company to report profit per share of $0.43, for the quarter. Analysts' estimates typically exclude special items. Fourth quarter net sales were $905 million, decreased 10.6% from last year. Organic sales decreased 10.7%.

On February 26, 2025, the Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share. The dividend is payable on April 11, 2025 to holders of record as of March 28, 2025.

Shares of Dentsply Sirona are down 2% in pre-market trade on Thursday.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.